IMEXPHARM Corporation Investor Presentation 2024

IMEXPHARM Corporation presents an investor overview of Vietnam's fast-growing pharmaceutical market, highlighting the nation's classification as a pharmerging market with double-digit growth potential. The presentation outlines Vietnam's national strategy for pharma development through 2030, targeting expansion from $8 billion to $16 billion in market value, with increasing local production contribution and EU-GMP manufacturing capacity.